Company Filing History:
2 out of 3,684 
2 out of 101 
1 out of 379 
Years Active: 2003-2009
Title: Innovations of James Wen
Introduction
James Wen is an accomplished inventor based in Dayton, NJ (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target cytokine production.
Latest Patents
James Wen holds three patents, with his latest focusing on N-heterocyclic inhibitors of TNF-α expression. These N-heterocyclic compounds are designed to block cytokine production through the inhibition of p38 kinase. The patents disclose methods of production, pharmaceutical compositions, and treatment methods for conditions associated with inappropriate p38 kinase activity or TNF-α expression.
Career Highlights
Throughout his career, James has worked with notable companies such as Bristol-Myers Squibb Company and Pharmacopeia, Inc. His work has been instrumental in advancing therapeutic options in the pharmaceutical industry.
Collaborations
James has collaborated with several professionals in his field, including Kevin Joseph Moriarty and Yvonne Class Shimshock. These collaborations have contributed to the success of his innovative projects.
Conclusion
James Wen's contributions to the field of pharmaceutical sciences through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of new therapeutic strategies.